Incyte to Present at Citi's 4th Annual Biotech Conference

Incyte Corporation (Nasdaq:INCY) announced today it will present at Citi's 4th Annual Biotech Day Conference on Wednesday, April 1, 2009 at 11:20 a.m. (Eastern Time).

Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and discuss its most advanced drug discovery and development programs.

The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 60 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation and diabetes.

Arizona Internet Marketing
Arizona Biotechnology Marketing
Biotechnology News